Elaros is a private digital health company incubated by NHS organisations, that represents a breakthrough, not only in terms of the innovative nature of its product development, but also in its partnership approach that brings together the NHS, the academic community and industry.
The NHS organisations involved in ELAROS are:
Devices for Dignity:a NIHR Healthcare Technology Co-operative set up to
drive forward innovative new products, processes and services to support people with long-term conditions, preserving their dignity and independence.
Devices for Dignity is hosted by Sheffield Teaching Hospitals NHS Foundation Trust.
Medipex Ltd and NHS Innovations North:
the UK NHS Innovation Hubs for Yorkshire & Humber and the North East Region. Their mission is to facilitate the development of services and products that cut costs and improve patient care.
Sheffield Teaching Hospital NHS Foundation Trust: who provide the clinical direction for ELAROS.
North Tyneside Clinical Commissioning Group: with whom Elaros is working to commercialiase the hydration monitoring system, Hydr8.
Elaros is a private digital health company incubated by NHS organisations, that adopts a partnership approach to product development, bringing together the NHS, the academic community and industry to develop solutions that are:
-Driven by unmet clinical need
-Co-designed and built with patients and clinicians
-Centred on powerful and validated algorithms
Elaros includes among its partners, the following organisations:
Dehydration in older people is among the top 10 reasons for hospital admission resulting in a significant financial impact on the healthcare system. Yet dehydration in older people can easily be prevented or treated with an appropriate hydration programme.
Hydr8 is a platform by which care homes can monitor the fluid intake of their residents. Each resident has their own profile on the Hydr8 app, where their fluid intake is recorded. The cumulative total can be viewed at a glance, with an infographic displaying the percentage of hydration status attained. Residents at risk of becoming under, or over, hydrated can easily be identified and a standardised protocol then guides staff to the appropriate response. Data from all residents is relayed back to a central data store which is accessible to the care home manager, care home provider, CCG and authorised clinicians.
Partners
Hydr8 was developed by North Tyneside Clinical Commissioning Group and Nine Software company Ltd, with support from the Academic Health Science Network, North East and North Cumbria.
Sleep is essential for human survival. Lack of adequate sleep leads to many detrimental health effects.
Common behavioural sleep problems include difficulties falling asleep, an inability to maintain sleep and early morning awakenings.
Evidence has shown that paediatric behavioural sleep programmes improve sleep duration in children and thus have a positive impact on the whole family. Using the Sleepy Fox app, carers are taught to understand the science behind sleep and to create a personalised bedtime plan along with strategies to help the child get a good night's sleep.
Partners and funding
Sleepy Fox was developed in collaboration with the Children's Sleep Charity and Sheffield Children's Hospital NHS Foundation Trust, supported by funding from the SBRI.
Dysphagia is a condition that affects the ability to swallow and affects many elderly people, including residents in care homes.
The swallowing mechanism changes significantly as people age and its disruption can have long-range health consequences in older adults, including dehydration and malnutrition.
The Guide is intended to be a one-stop shop for care home staff from caterers and care home assistants to care home managers and care home policy makers. It includes essential information about dysphagia, recipes suitable for residents with swallowing difficulties and specialist training modules for catering staff. It is accessible on Android or iOS tablets.
Partners and funding
The Guide was developed in collaboration with Luto, Making Sense Ltd and experts in dysphagia from Sheffield Teaching Hospitals NHS Foundation Trust, supported by funding from Innovate UK and the Abbeyfield Research Foundation.
At some point in their life two out of every three adults will have a bladder related problem, requiring a visit to their GP to identify the problem. Currently, people presenting to their GP with bladder problems are required to complete a paper diary that is then returned to their GP for analysis.
The Digital Bladder Diary replaces the paper diary with a hand held recording device that enables people to monitor their own health safely and discreetly.
The process of recording information is simple, and enables the patient to take control and management of their bladder issues with dignity. The device is discreet and convenient and the information captured is 100% secure. Using the device enables the patient to keep an accurate up to date bladder diary wherever they are.
The information gathered using the diary is uploaded remotely to the cloud which provides an immediate clinical diagnosis and recommended clinical action.
Use of the device ensures accurate clinical analysis of data resulting in greatly reduced clinical referrals and unnecessary hospital visits. The time taken to diagnose and treat a patient's symptoms is cut, reducing anxiety for the patient and offering quick relief from symptoms.
This innovative new way of carrying out initial assessment, diagnosis and triaging of patients with long-term conditions has been specifically designed to be integrated into GP practices, specialist continence providers, community health organisations and acute trusts. The service enhances delivery of the patient pathway and enables compliance with NICE guidelines.
Partners
The Digital Bladder diary was developed in collaboration with urology experts from Sheffield Teaching Hospitals NHS Foundation Trust, with support from the Yorkshire and Humber Academic Health Science Network.
Professor Paul O' Brien was appointed CEO of Elaros 24/7 in April 2012. Paul has held senior
posts in the private sector (Chief Executive), local government (Chief Officer), health (Director in West Essex NHS Trust) and education (Head of Department).
He has previous venture start-up experience having established the Essex Development and Regeneration Agency with a turnover of £8.5 million and funds under management of £15 million - employing 60 planners, economists, surveyors, bid writers and fund managers.
He has extensive experience of public sector transformation having externalised a local government service and more recently the externalisation of a £33 Million NHS Service.
Paul also has broad non-executive board experience gained over a 15 year period and has completed the Institute of Directors Diploma in Company Direction.
He is a visiting lecturer to the University of Surrey on its MBA & MSc Entrepreneurship programmes.
Professor Christopher Chapple is a Consultant Urological Surgeon at Sheffield
Teaching Hospitals and Visiting Professor at Sheffield Hallam University. He has a particular interest in functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms
and provides a tertiary service in lower urinary tract reconstructive surgery. He trained at the Middlesex Hospital where he subsequently completed his doctorate thesis, and continued there and at the Institute
of Urology in London for his sub-specialist training.
He is Chairman of the International Relations Committee at the European Association of Urology, having previously been the Adjunct Secretary General responsible for Education and Past Director of the European School of Urology. He is editor-in-chief of the journal Neurourology and Urodynamics and is on the editorial board of several journals such as the British Journal of Urology, European Urology, Surgery and Current Opinion in Urology. He is an active member of many international urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He has chaired a number of guidelines initiatives including the NICE Guidelines Development Group on male lower urinary tract symptoms. He was awarded the St Peter’s medal by the British Association of Urological Surgeons in 2011. Professor Chapple has co-authored over 350 articles in peer-reviewed Journals and has written several books and a number of book chapters.
Peter Cunliffe qualified as a Chartered Accountant in 1983, having trained in Birmingham with one of
the then ‘Big 4’ accountancy firms, Deloitte Haskins and Sells.
Since qualifying, Peter has worked in various finance and accounting roles for a wide spectrum of businesses, both in terms of size (£3m up to £1.2bn turnover) and industry sector (including retail, engineering, steel stockholding, laboratory analysis and specialty chemicals).
His early positions were in large blue-chip companies, roles which gave him a full understanding of the importance of pertinent, current management information and the need for strict financial disciplines to augment performance and safeguard assets.
Recognising that most small companies do not need a full-time financial director, Peter set up Flex FD Ltd in 2004, providing a flexible financial direction service for start-up and early-stage companies, particularly in the life science and healthcare sectors, and has helped raise £7m in funding across 10 businesses.
Please get in touch by phone, email or twitter and a member of our team will respond to discuss your enquiry.
We aim to keep the information on our website accurate but if errors are brought to our attention we will endeavour to correct them. We reserve the right to withdraw any of the content of this site at any time and we don't accept responsibility for the content of third party websites.
We don't collect Cookies, but if you contact us via our website, your name, e-mail address and your message will be e-mailed to us. We will keep your information private and won't release it to third parties, unless we have your permission to do so.
The information you send us, may be used to keep you informed of Elaros’ developments. If you no longer wish to receive information, please e-mail us on: hello@elaros.com
